A Phase 3, Multicenter, Randomized, Double-blind Study t

Project: Research project

Project Details

Description

A Phase 3, Multicenter, Randomized, Double-blind Study to Determine the Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects with Mild to Moderate Ulcerative Colitis, in both Acute and Maintenance Phases
StatusFinished
Effective start/end date7/8/1512/31/18

Funding

  • Shire Development Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.